• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用凝胶模型检测全尿的结晶抑制活性。

Detection of crystallization inhibitory activity of whole urine with a gel model.

作者信息

Li M K, Shum D K, Choi S

出版信息

Urol Res. 1987;15(2):75-7. doi: 10.1007/BF00260936.

DOI:10.1007/BF00260936
PMID:3590432
Abstract

The inhibitory activity of urine on calcium oxalate crystallization was measured as an inhibitory index using a gel model modified from Schneider et al. [8]. Urine samples from 36 recurrent stone formers and 21 controls in 3 separate periods (morning, afternoon and evening) were tested. Mean inhibitory indices of greater than 0 were observed among normal controls in the 3 sampled periods and among stone formers in the morning and afternoon samples. A significantly lower (negative) value was observed in the evening samples of stone formers, indicating a higher tendency towards crystallization than normal. The gel method may be applied to identify individuals at risk of stone formation if sufficient numbers of period-defined urine samples from the individual are tested for a statistically significant mean inhibitory index but whether this is practical in a clinical laboratory will need further evaluations.

摘要

采用经施耐德等人[8]改良的凝胶模型,以抑制指数来衡量尿液对草酸钙结晶的抑制活性。对36名复发性结石形成者和21名对照者在3个不同时间段(上午、下午和晚上)采集的尿液样本进行了检测。在3个采样时间段的正常对照者以及结石形成者上午和下午的样本中,均观察到平均抑制指数大于0。结石形成者晚上的样本中观察到显著较低(阴性)的值,表明其结晶倾向高于正常人。如果对个体足够数量的按时间段定义的尿液样本进行检测,以获得具有统计学意义的平均抑制指数,凝胶法可用于识别有结石形成风险的个体,但这在临床实验室是否可行还需要进一步评估。

相似文献

1
Detection of crystallization inhibitory activity of whole urine with a gel model.用凝胶模型检测全尿的结晶抑制活性。
Urol Res. 1987;15(2):75-7. doi: 10.1007/BF00260936.
2
Circadian variations in the risk of urinary calcium oxalate stone formation.草酸钙肾结石形成风险的昼夜节律变化。
Br J Urol. 1994 Sep;74(3):294-7. doi: 10.1111/j.1464-410x.1994.tb16613.x.
3
Separate effects of urinary chondroitin sulphate and heparan sulphate on the crystallization of urinary calcium oxalate: differences between stone formers and normal control subjects.硫酸软骨素和硫酸乙酰肝素对草酸钙结晶的单独作用:结石形成者与正常对照受试者之间的差异
Clin Sci (Lond). 1993 Jul;85(1):33-9. doi: 10.1042/cs0850033.
4
Circadian periodicity of urinary inhibitor of calcium oxalate crystallization in healthy Indians and renal stone formers.健康印度人和肾结石患者中草酸钙结晶尿抑制剂的昼夜节律。
Eur Urol. 1993;24(3):387-92. doi: 10.1159/000474334.
5
Relationship between supersaturation and calcium oxalate crystallization in normals and idiopathic calcium oxalate stone formers.正常人及特发性草酸钙结石患者中过饱和度与草酸钙结晶的关系。
Kidney Int. 1999 Mar;55(3):1041-50. doi: 10.1046/j.1523-1755.1999.0550031041.x.
6
Urinary inhibitory activity of calcium oxalate monohydrate crystal growth in stone-formers & non stone-formers.
Indian J Med Res. 1987 Oct;86:500-5.
7
[Clinical studies of the recurrence of urolithiasis (4). Crystal formation in urine and stone recurrence].尿路结石复发的临床研究(4)。尿液中晶体形成与结石复发
Hinyokika Kiyo. 1988 Sep;34(9):1543-7.
8
Inhibitory effect of bikunin on calcium oxalate crystallization in vitro and urinary bikunin decrease in renal stone formers.比卡宁对草酸钙结晶的体外抑制作用及肾结石患者尿比卡宁水平降低
Urol Res. 1999;27(1):69-75. doi: 10.1007/s002400050091.
9
Inhibition of calcium oxalate crystallization in urine.尿液中草酸钙结晶的抑制作用。
Urol Res. 1987;15(2):83-6. doi: 10.1007/BF00260938.
10
Calcium oxalate crystallization properties in urine with different specific electrical conductivities.不同比电导率尿液中草酸钙的结晶特性。
J Urol. 1992 Sep;148(3 Pt 2):990-4. doi: 10.1016/s0022-5347(17)36797-6.

引用本文的文献

1
Chinese herbal medicines and their efficacy in treating renal stones.中草药及其在治疗肾结石方面的功效。
Urol Res. 2006 Dec;34(6):365-72. doi: 10.1007/s00240-006-0068-y.
2
The dual effect of urinary macromolecules on the crystallization of calcium oxalate endogenous in urine.尿液中大分子物质对尿液内源性草酸钙结晶的双重作用。
Urol Res. 1992;20(1):13-7. doi: 10.1007/BF00294328.

本文引用的文献

1
Effects of high molecular weight urinary macromolecules on crystallization of calcium oxalate dihydrate.高分子量尿大分子对二水合草酸钙结晶的影响。
J Urol. 1982 Apr;127(4):805-10. doi: 10.1016/s0022-5347(17)54054-9.
2
A gel model for measuring crystallization inhibitor activities.一种用于测量结晶抑制剂活性的凝胶模型。
Urol Int. 1983;38(1):33-8. doi: 10.1159/000280858.
3
A micropuncture and renal clearance study in the rat of the urinary excretion of heparin, chondroitin sulphate and metabolic breakdown products of connective tissue proteoglycans.
Clin Sci (Lond). 1984 Aug;67(2):205-12. doi: 10.1042/cs0670205.
4
The recognition and isolation from urine and serum of a peptide inhibitor to calcification.从尿液和血清中识别并分离出一种钙化肽抑制剂。
Johns Hopkins Med J. 1967 Mar;120(3):119-36.
5
Circadian rhythms and the urinary excretion of acid glycosaminoglycans in normal human adults.正常成年人的昼夜节律与酸性糖胺聚糖的尿排泄
Connect Tissue Res. 1979;7(1):47-55. doi: 10.3109/03008207909152352.
6
Glycosaminoglycans as inhibitors of calcium oxalate crystal growth and aggregation.糖胺聚糖作为草酸钙晶体生长和聚集的抑制剂。
Clin Chim Acta. 1979 Jul 2;95(1):23-28. doi: 10.1016/0009-8981(79)90332-2.
7
Risk factors in calcium stone disease of the urinary tract.
Br J Urol. 1978 Dec;50(7):449-54. doi: 10.1111/j.1464-410x.1978.tb06189.x.